Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2023

Mar 29, 2023

32044_dirs_2023-03-28_c3a52282-250e-4b9a-890f-482138a231fe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2023-03-24

Reporting Person: Thomasian Harry Jr. (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-24 Common Stock M 35868 Acquired 120829 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-24 Restricted Stock Units $ A 107605 Acquired Common Stock (107605) Direct
2023-03-24 Restricted Stock Units $ M 35868 Disposed Common Stock (35868) Direct
2023-03-24 Option to Purchase Common Stock (Right to Buy) $0.96 A 46815 Acquired 2033-03-24 Common Stock (46815) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

F2: 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023.

F3: Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately.